PT  - JOURNAL ARTICLE
AU  - Widdice, Lea E.
AU  - Kahn, Jessica A.
TI  - Using the new HPV vaccines in clinical practice
DP  - 2006 Oct 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 929--935
VI  - 73
IP  - 10
4099  - http://www.ccjm.org/content/73/10/929.short
4100  - http://www.ccjm.org/content/73/10/929.full
SO  - Cleve Clin J Med2006 Oct 01; 73
AB  - Gardasil, a vaccine against human papillomavirus (HPV), recently became available in the United States for use in girls and women 9 to 26 years of age. A second HPV vaccine, Cervarix, is under development. These vaccines constitute the most significant development in cervical cancer prevention in the last 60 years, having the potential to reduce the incidence of cervical cancer by up to 70%.